首頁
Haematologic Technologies

6月 2026Haematologic Technologies的市場佔有率分析

prolytix, formerly haematologic technologies, provides full bioanalysis and protein chemistry services, research reagents, and collection devices.

科學與教育 > 生物學

域名haemtech.com

成立年份1987

僱員51 - 200

年度營收$10M - $15M

Haematologic Technologies

Haematologic Technologies（包含公司地區）

haemtech.com

查看更多網站流量與參與度資訊

Haematologic Technologies截至 6月 2026 的總收入為 10M - 15M

Haematologic Technologies 熱門網域產生的總收入

Haematologic Technologies 熱門網域 3 年內的總收入

Haematologic Technologies 熱門網域的總收入

haemtech.com10M - 15M

透過銷售情報查看更多內容

Haematologic Technologies的熱門網域總造訪量

了解Haematologic Technologies市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Haematologic Technologies的熱門網域平均造訪時長

分析Haematologic Technologies參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Haematologic Technologies的熱門網域平均頁面瀏覽量

了解Haematologic Technologies如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Haematologic Technologies按網域劃分的熱門競爭對手

6月 2026的熱門類似網站，依相似度排名

ptglab.com公司名Proteintech Group僱員201 - 500總部美國, 伊利諾伊州, Rosemont年度營收$25M - $50M訪問總量388.7K科學與教育 > 生物學

使用的熱門技術Haematologic Technologies

这些是Haematologic Technologies顶级域名使用的行业网站技术

社群 (7)

Google+ Platform

小工具 (4)

Twemoji

內容管理系統 (2)

WordPress

轉換與分析 (2)

Google Analytics

更多技術

7

檢視所有

新聞與訊號來自Haematologic Technologies

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Haematologic Technologies, Inc. hired Joe Flynn as Chief Commercial Officer on Jan 6th '22.Haematologic Technologies ("HT"), a global leader in large molecule analytical services and plasma reagents, today announced the appointment of Joe Flynn as Chief Commercial Officer.

新聞Haematologic Technologies, Inc. hired John Strokis as Vice President, Quality on Dec 16th '21.Haematologic Technologies ("HT"), a global leader in large molecule bioanalysis and biologic reagents, today announced the appointment of John Strokis as Vice President, Quality.

新聞Haematologic Technologies, Inc. launched High Resolution Mass Spectrometry on Oct 1st '20.Haematologic Technologies (HTI), a leading protein chemistry company providing products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics, today announced the addition of a High Resolution Mass Spectrometry (HRMS) lab headed by Kevin Van Cott, PhD, a global expert in the use of HRMS for Host Cell Proteins (HCP) and biotherapeutics characterization.